antimicrobial

Probing hellbender health

Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights.

Ritu Banerjee, MD, PhD, and her colleagues are studying a new way to determine whether antibiotics will be effective against certain bacterial infections.

VUMC awarded CDC funding to combat antimicrobial resistance, infectious diseases

Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).

Frog peptides as anti-HIV microbicides

Peptides derived from the antimicrobial peptides secreted by frogs could function as microbicides to limit HIV transmission, while sparing protective vaginal bacteria.

The adaptable anthrax bacterium

Vanderbilt researchers discover how anthrax bacterium defends itself against structural damage and resists the toxicity of the antimicrobial drug targocil.

Katz awarded LEAP Fellowship to improve antibiotic use in Tennessee

Sophie Katz, MD, MPH, is one of four early career infectious diseases physicians in the United States to receive the award, which provides $100,000 of funding support from the Centers for Disease Control and Prevention.

Program seeks to optimize appropriate use of antibiotics

Relying on a core team of physicians and pharmacists, the Vanderbilt Antimicrobial Stewardship Program (VASP) is seeking to ensure optimum use of antibiotics and other antimicrobial drugs at Vanderbilt University Medical Center (VUMC).